US EditionSeattle Biotech Giant Sana Pulls Plug on Bothell Manufacturing, Records $44.6MM Facility Loss - The Registry
Summary by The Registry
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Seattle Biotech Giant Sana Pulls Plug on Bothell Manufacturing, Records $44.6MM Facility Loss - The Registry
Biotech company writes down facilities amid shift to outsourced production and mounting losses Sana Biotechnology recorded a $44.6 million impairment charge in the second quarter as the cell therapy developer abandoned plans for internal manufacturing, highlighting the financial strain facing the Seattle-based company as it burns through cash while advancing experimental treatments. The non-cash write-down primarily affected the company’s manufa…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
